TG Therapeutics, Inc.

TGTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001001316

SEC filings (opens in a new tab)

In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 431 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding TG Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022 All holders in Q2 2022

13F holders of TGTX: Q2 2022 compared with Q3 2022
Measure	Q2 2022	Q3 2022	Change
Holders	175	183	+8
Shares	106.4M	100.2M	−6.21M (−5.8%)
Value	$452.6M	$594.6M	+$142.0M (+31.4%)

New holders (32)

Institutions that held TG Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to TGTX in Q3 2022
Institution	Shares	Value	% of portfolio
Woodline Partners LP	934,436	$5.53M	0.08%
Point72 Asset Management, L.P.	437,200	$2.59M	0.01%
Squarepoint Ops LLC	116,138	$688.0K	0.01%
Jacobs Levy Equity Management, Inc	112,495	$666.0K	0.01%
HRT Financial LP	85,977	$508.0K	0.01%
SG Americas Securities, LLC	66,443	$393.0K	0.01%
Spotlight Asset Group, Inc.	75,000	$391.0K	0.39%
Virginia Retirement Systems Et Al	53,200	$314.9K	0.00%
Tudor Investment Corp Et Al	44,841	$265.0K	0.01%
Trexquant Investment LP	35,369	$209.0K	0.01%
Y-Intercept (Hong Kong) Ltd	33,234	$196.7K	0.02%
Bartlett & Co. LLC	25,000	$148.0K	0.00%
Russell Investments Group, Ltd.	25,252	$148.0K	0.00%
Bartlett & Co. Wealth Management LLC	25,000	$148.0K	0.00%
Cowen and Company, LLC	112,000	$129.0K	0.01%
DuPont Capital Management Corp	20,914	$124.0K	0.01%
Bridgefront Capital, LLC	19,845	$117.0K	0.12%
Clark Financial Services Group Inc	17,204	$102.0K	0.11%
Avaii Wealth Management, LLC	13,917	$82.0K	0.09%
Amundi	12,594	$79.0K	0.00%
Blueshift Asset Management, LLC	12,914	$76.0K	0.02%
Davenport & Co LLC	12,200	$72.0K	0.00%
HC Advisors, LLC	11,500	$68.0K	0.05%
Brookstone Capital Management	11,725	$67.0K	0.00%
Balyasny Asset Management LLC	10,499	$62.0K	0.00%
Cipher Capital LP	10,499	$62.0K	0.01%
LMR Partners LLP	10,000	$59.0K	0.00%
Fifth Third Bancorp	4,569	$27.0K	0.00%
Money Concepts Capital Corp	124	$1.00K	0.00%
Allworth Financial LP	100	$1.00K	0.00%
Axiom Investment Management LLC	62	$0	0.00%
Ronald Blue Trust, Inc.	108	$0	0.00%

Sold out (24)

Institutions that held TG Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of TGTX in Q3 2022
Institution	Shares, Q2 2022	Value, Q2 2022
Assenagon Asset Management S.A.	2,088,952	$8.88M
Antara Capital LP	900,000	$3.83M
Eagle Asset Management Inc	701,690	$2.98M
Occudo Quantitative Strategies LP	567,576	$2.41M
Walleye Capital LLC	198,233	$842.0K
AlphaCrest Capital Management LLC	77,224	$328.0K
Caxton Associates LP	68,677	$292.0K
STRS Ohio	26,900	$114.0K
Cook Wealth Management Group LLC	12,810	$96.0K
Delphia (USA) Inc.	12,867	$55.0K
Virtu Financial LLC	12,191	$52.0K
Corton Capital Inc.	11,748	$50.0K
Chiron Capital Management, LLC	10,717	$46.0K
Prospera Financial Services Inc	6,700	$28.0K
Lazard Asset Management LLC	6,327	$26.0K
Walleye Trading LLC	5,122	$22.0K
Parallax Volatility Advisers, L.P.	4,245	$18.0K
GoalVest Advisory LLC	1,284	$7.00K
Trustcore Financial Services, LLC	600	$3.00K
Johnson Financial Group, Inc.	500	$2.00K
Venture Visionary Partners LLC	300	$1.27K
American Portfolios Advisors	210	$893
Institutional & Family Asset Management, LLC	11	$0
Vectors Research Management, LLC	100	$0